ArticleFrontiers in nutrition2026
Which critically ill patients are more susceptible to the adverse effects associated with feeding intolerance? A secondary analysis of a cluster-randomized controlled trial.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: It remains unclear which critically ill patients are more susceptible to the adverse effects associated with feeding intolerance (FI), which is common in patients receiving early enteral nutrition (EEN). Therefore, we aimed to explore the association between FI and short-term outcomes in critically ill patients receiving EEN. Methods: This secondary analysis of a multicenter cluster-randomized controlled trial included patients who initiated enteral nutrition within 48 h of admission and received it for at least 3 days. We utilized univariate and multivariate propensity score-weighted logistic regression analyses to investigate the association between FI and 28-day mortality. We conducted multiple subgroup analyses to identify subcohorts that are more likely to be adversely impacted by FI. Results: A total of 1,545 patients were included in the final analysis, among whom 856 experienced FI and 689 did not. In univariate analyses, no association was found between FI and 28-day mortality [odds ratio (OR) 1.302, 95% CI 0.967-1.752, Conclusion: In critically ill patients receiving EEN, FI was associated with higher 28-day mortality, longer ICU LOS, fewer ventilator-free days and ICU-free days. Elderly patients, those with a normal BMI, those with a primary diagnosis of respiratory diseases, and those with a SOFA score of ≤ 8 may be more susceptible to adverse effects of FI. However, these subgroup findings should be interpreted cautiously given multiple comparisons.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.